Physician profile
Walter P Jacobsen
NPI 1649419169
$19,183.38
in general payments reported to CMS, 2019-2025
11 companies · $5,425 in 2025
The $5,425 reported for 2025 was more than what 81% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $671 · 2020: $1,912 · 2021: $1,706 · 2022: $629 · 2023: $7,749 · 2024: $1,091 · 2025: $5,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,956 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250 · Travel and Lodging: $2,091 · Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,956.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
| Travel and Lodging | $2,091.35 |
| Food and Beverage | $967.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15,730.97 | 2019-2025 | Alif Instruments (Universal), Magnify, Mars 3v/3vl |
| Stryker Corporation | $1,787.40 | 2019-2021 | |
| Sanara Medtech INC. | $665.39 | 2021-2025 | Celleraterx, Celleraterx |
| W. L. Gore & Associates, INC. | $499.87 | 2019 | |
| Nuvasive, INC. | $171.99 | 2022-2023 | Maxcess, Affix, Reline |
| Ctl Medical Corporation | $153.59 | 2020-2021 | |
| Medtronic USA, INC. | $60.24 | 2019 | |
| Orthofix Medical, INC. | $36.00 | 2019-2023 | Spinal-Stim, Spinal-Stim |
| 4web, INC. | $34.51 | 2021 | |
| Baxter Healthcare | $29.16 | 2022-2025 | Floseal |
| Heron Therapeutics, INC. | $14.26 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Jacobsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.